Beta Drugs Market Cap

Beta Drugs has a market cap or net worth of 17.11 billion as of May 2, 2025. Its market cap has increased by 36.42% in one year.

Market Cap

17.11B

Enterprise Value

17.02B

Revenue

3.35B

Ranking

n/a

PE Ratio

41.73

Stock Price

1,695.05

Market Cap Chart

Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 17.11B, an increase of 1,768.01%. That is a compound annual growth rate of 47.57%.

Market Cap History

Date	Market Cap	% Change
May 2, 2025	17.11B	-11.41%
Dec 31, 2024	19.31B	36.67%
Dec 29, 2023	14.13B	107.04%
Dec 30, 2022	6.83B	10.89%
Dec 31, 2021	6.16B	497.76%
Dec 31, 2020	1.03B	56.85%
Dec 27, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	18.07T
HDFC Bank	14.74T
Tata Consultancy Services	12.46T
Bharti Airtel	11.10T
ICICI Bank	10.21T
State Bank of India	7,139.70B
Infosys	6,243.59B
Bajaj Finance	5,498.65B

Market Cap Rankings